Canada · Federal contract register · Contract
Pharmaceutical and other medicinal products — Canada · Federal contract register · Contract: $207.0K contract value ($207,000); No competition how it was bought (no competition); 2023 contract date (27 February 2023).
Assay record ASY-CA-0TY9SI41SS · Cite as: Assay Systems, “Pharmaceutical and other medicinal products · National Defence · CRO, LLC (CRO Medical) DBA POLYSERP Therapeutics”, https://assay-systems.com/register/ca/contract/c-2024-2025-q1-04919/
| Department | National Defence |
|---|---|
| Supplier | CRO, LLC (CRO Medical) DBA POLYSERP Therapeutics |
| Contract date | 27 February 2023 |
| Period | 27 February 2023 – 31 March 2025 |
| Value | $207,000 |
| Original value | $103,500 |
| Amendments | $103,500 |
| Procedure | Non-competitive (no competition) |
| Bids received | not stated |
| Economic object code | 1132 |
The department awarded it without a competition. CRO, LLC (CRO Medical) DBA POLYSERP Therapeutics took $207,000 with no other bid on the table.
Proactive disclosure of contracts over $10,000, Government of Canada, open.canada.ca, under the Open Government Licence – Canada. Where a contract was amended, the page carries the last report filed for it.
Contains information licensed under the Open Government Licence – Canada.Source: Government of Canada proactive disclosure of contracts.